ACTA1
Basic information
Region (hg38): 1:229430365-229434104
Previous symbols: [ "ACTA" ]
Links
Phenotypes
GenCC
Source:
- congenital myopathy 2a, typical, autosomal dominant (Strong), mode of inheritance: AR
- congenital myopathy 2a, typical, autosomal dominant (Definitive), mode of inheritance: Semidominant
- congenital fiber-type disproportion myopathy (Supportive), mode of inheritance: AD
- zebra body myopathy (Supportive), mode of inheritance: Unknown
- rigid spine syndrome (Supportive), mode of inheritance: AR
- severe congenital nemaline myopathy (Supportive), mode of inheritance: AR
- intermediate nemaline myopathy (Supportive), mode of inheritance: AD
- typical nemaline myopathy (Supportive), mode of inheritance: AD
- childhood-onset nemaline myopathy (Supportive), mode of inheritance: AD
- progressive scapulohumeroperoneal distal myopathy (Supportive), mode of inheritance: AD
- congenital myopathy with excess of thin filaments (Definitive), mode of inheritance: Semidominant
- congenital myopathy 2c, severe infantile, autosomal dominant (Strong), mode of inheritance: AD
- congenital myopathy 2a, typical, autosomal dominant (Strong), mode of inheritance: AD
- alpha-actinopathy (Definitive), mode of inheritance: AR
- alpha-actinopathy (Definitive), mode of inheritance: AD
- congenital myopathy 2a, typical, autosomal dominant (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital myopathy 2C, severe infantile, autosomal dominant; Myopathy, congenital, with fiber-type disproportion 1; Congenital myopathy 2A, severe infantile or typical, autosomal dominant; Myopathy, scapuloperoneal; Congenital myopathy 2A, typical, autosomal dominant; Congenital myopathy 2B, severe infantile, autosomal recessive | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 4952447; 9185179; 10508519; 11333380; 11558787; 15236405; 15520409; 15468086; 16427282; 17187373; 19553116; 22442437; 25182138; 25938801; 27242277 |
ClinVar
This is a list of variants' phenotypes submitted to
- Actin accumulation myopathy (72 variants)
- not provided (10 variants)
- Congenital myopathy with fiber type disproportion (2 variants)
- Congenital myopathy 2c, severe infantile, autosomal dominant (2 variants)
- Nemaline myopathy 3, autosomal dominant or recessive (1 variants)
- Actin accumulation myopathy;ACTA1 gene related myopathy (1 variants)
- Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita (1 variants)
- ACTA1-related disorder (1 variants)
- Neuromuscular disease (1 variants)
- Progressive scapulohumeroperoneal distal myopathy (1 variants)
- Inborn genetic diseases (1 variants)
- See cases (1 variants)
- Non-immune hydrops fetalis (1 variants)
- Nemaline myopathy (1 variants)
- Myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACTA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 64 | 69 | ||||
missense | 66 | 80 | 122 | 268 | ||
nonsense | 6 | |||||
start loss | 2 | |||||
frameshift | 16 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 10 | 6 | 2 | 18 | ||
non coding | 50 | 13 | 72 | |||
Total | 80 | 96 | 143 | 114 | 13 |
Highest pathogenic variant AF is 0.0000131
Variants in ACTA1
This is a list of pathogenic ClinVar variants found in the ACTA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-229431173-C-CT | Likely benign (Apr 10, 2019) | |||
1-229431251-C-T | Familial restrictive cardiomyopathy • Congenital myopathy with fiber type disproportion • Actin accumulation myopathy | Conflicting classifications of pathogenicity (Jan 12, 2018) | ||
1-229431433-C-T | Actin accumulation myopathy • Familial restrictive cardiomyopathy • Congenital myopathy with fiber type disproportion | Uncertain significance (Jan 12, 2018) | ||
1-229431440-G-GC | Likely benign (Sep 05, 2018) | |||
1-229431501-A-G | Actin accumulation myopathy | Pathogenic (Feb 04, 2022) | ||
1-229431503-A-G | Actin accumulation myopathy | Likely pathogenic (Mar 08, 2019) | ||
1-229431505-G-A | Congenital myopathy with fiber type disproportion • Familial restrictive cardiomyopathy • Actin accumulation myopathy | Conflicting classifications of pathogenicity (Jan 08, 2023) | ||
1-229431506-C-A | Actin accumulation myopathy | Pathogenic/Likely pathogenic (Jul 25, 2022) | ||
1-229431506-C-G | Alpha-actinopathy | Pathogenic (Aug 27, 2024) | ||
1-229431506-C-T | Actin accumulation myopathy | Uncertain significance (Jan 21, 2022) | ||
1-229431508-T-C | Familial restrictive cardiomyopathy • Congenital myopathy with fiber type disproportion • Actin accumulation myopathy | Conflicting classifications of pathogenicity (Dec 09, 2023) | ||
1-229431508-T-G | Nemaline myopathy | Likely pathogenic (Jun 09, 2009) | ||
1-229431510-T-C | Actin accumulation myopathy | Likely pathogenic (Dec 21, 2020) | ||
1-229431514-G-C | Likely pathogenic (Nov 01, 2022) | |||
1-229431520-G-C | Familial restrictive cardiomyopathy • Actin accumulation myopathy • Congenital myopathy with fiber type disproportion | Uncertain significance (Jan 13, 2018) | ||
1-229431524-G-T | Actin accumulation myopathy | Uncertain significance (Jul 19, 2017) | ||
1-229431527-G-A | Actin accumulation myopathy | Likely pathogenic (Sep 05, 2021) | ||
1-229431527-G-T | Myopathy | Uncertain significance (May 08, 2019) | ||
1-229431529-G-A | Alpha-actinopathy • not specified | Likely benign (Aug 27, 2024) | ||
1-229431532-G-A | Uncertain significance (Dec 01, 2016) | |||
1-229431535-C-T | Actin accumulation myopathy | Likely benign (Mar 17, 2022) | ||
1-229431540-CG-C | Alpha-actinopathy | Likely pathogenic (Aug 07, 2024) | ||
1-229431550-C-T | Actin accumulation myopathy | Likely benign (Aug 03, 2022) | ||
1-229431558-T-C | Actin accumulation myopathy | Likely pathogenic (Jun 19, 2022) | ||
1-229431558-T-G | Congenital myopathy 2c, severe infantile, autosomal dominant | Pathogenic (Jun 01, 2001) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACTA1 | protein_coding | protein_coding | ENST00000366684 | 6 | 2854 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000114 | 0.586 | 125706 | 0 | 42 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.53 | 55 | 261 | 0.211 | 0.0000176 | 2498 |
Missense in Polyphen | 22 | 126.98 | 0.17325 | 1140 | ||
Synonymous | 1.11 | 102 | 117 | 0.870 | 0.00000992 | 744 |
Loss of Function | 0.934 | 11 | 14.9 | 0.739 | 6.45e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000145 | 0.000145 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000931 | 0.0000924 |
European (Non-Finnish) | 0.000204 | 0.000185 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000425 | 0.000392 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.;
- Disease
- DISEASE: Nemaline myopathy 3 (NEM3) [MIM:161800]: A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. {ECO:0000269|PubMed:10508519, ECO:0000269|PubMed:11166164, ECO:0000269|PubMed:11333380, ECO:0000269|PubMed:15198992, ECO:0000269|PubMed:15236405, ECO:0000269|PubMed:15336687, ECO:0000269|PubMed:15520409, ECO:0000269|PubMed:16427282, ECO:0000269|PubMed:16945537, ECO:0000269|PubMed:17705262, ECO:0000269|PubMed:22442437, ECO:0000269|PubMed:23650303, ECO:0000269|PubMed:25938801}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, actin, congenital, with excess of thin myofilaments (MPCETM) [MIM:161800]: A congenital muscular disorder characterized at histological level by areas of sarcoplasm devoid of normal myofibrils and mitochondria, and replaced with dense masses of thin filaments. Central cores, rods, ragged red fibers, and necrosis are absent. {ECO:0000269|PubMed:10508519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:15468086, ECO:0000269|PubMed:17387733}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, scapulohumeroperoneal (SHPM) [MIM:616852]: An autosomal dominant muscular disorder characterized by progressive muscle weakness with initial scapulo-humeral-peroneal and distal distribution. Over time, muscle weakness progresses to proximal muscle groups. Clinical characteristics include scapular winging, mild lower facial weakness, foot drop due to foot eversion and dorsiflexion weakness, and selective muscle atrophy. Age at onset and disease progression are variable. {ECO:0000269|PubMed:25938801}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Myometrial Relaxation and Contraction Pathways;Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation;Association Between Physico-Chemical Features and Toxicity Associated Pathways;Striated Muscle Contraction;erk and pi-3 kinase are necessary for collagen binding in corneal epithelia;ucalpain and friends in cell spread;integrin signaling pathway;induction of apoptosis through dr3 and dr4/5 death receptors;vegf hypoxia and angiogenesis;mcalpain and friends in cell motility;nfat and hypertrophy of the heart ;stress induction of hsp regulation;TCR;cell to cell adhesion signaling;agrin in postsynaptic differentiation;role of mal in rho-mediated activation of srf;Caspase Cascade in Apoptosis;Signaling events mediated by focal adhesion kinase;AP-1 transcription factor network;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.937
Intolerance Scores
- loftool
- 0.244
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.62
Haploinsufficiency Scores
- pHI
- 0.906
- hipred
- Y
- hipred_score
- 0.802
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acta1
- Phenotype
- skeleton phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- acta1b
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- muscle contraction;response to mechanical stimulus;response to extracellular stimulus;response to lithium ion;positive regulation of gene expression;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle fiber adaptation;response to steroid hormone;skeletal muscle fiber development;cellular response to organonitrogen compound;mesenchyme migration
- Cellular component
- stress fiber;extracellular space;cytosol;striated muscle thin filament;actin filament;actin cytoskeleton;sarcomere;lamellipodium;filopodium;cell body;extracellular exosome;blood microparticle
- Molecular function
- structural constituent of cytoskeleton;protein binding;ATP binding;myosin binding;ADP binding